Literature DB >> 33571972

The use of dose quantities in radiological protection: ICRP publication 147 Ann ICRP 50(1) 2021.

J D Harrison1,2, M Balonov3, F Bochud4, C J Martin5, H-G Menzel6, R Smith-Bindman7, P Ortiz-López8, J R Simmonds2,9, R Wakeford10.   

Abstract

The International Commission on Radiological Protection has recently published a report (ICRP Publication 147;Ann. ICRP50, 2021) on the use of dose quantities in radiological protection, under the same authorship as this Memorandum. Here, we present a brief summary of the main elements of the report. ICRP Publication 147 consolidates and clarifies the explanations provided in the 2007 ICRP Recommendations (Publication 103) but reaches conclusions that go beyond those presented in Publication 103. Further guidance is provided on the scientific basis for the control of radiation risks using dose quantities in occupational, public and medical applications. It is emphasised that best estimates of risk to individuals will use organ/tissue absorbed doses, appropriate relative biological effectiveness factors and dose-risk models for specific health effects. However, bearing in mind uncertainties including those associated with risk projection to low doses or low dose rates, it is concluded that in the context of radiological protection, effective dose may be considered as an approximate indicator of possible risk of stochastic health effects following low-level exposure to ionising radiation. In this respect, it should also be recognised that lifetime cancer risks vary with age at exposure, sex and population group. The ICRP report also concludes that equivalent dose is not needed as a protection quantity. Dose limits for the avoidance of tissue reactions for the skin, hands and feet, and lens of the eye will be more appropriately set in terms of absorbed dose rather than equivalent dose.
© 2021 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Entities:  

Keywords:  ICRP; dose quantities; effective dose; stochastic effects; tissue reactions

Year:  2021        PMID: 33571972     DOI: 10.1088/1361-6498/abe548

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  6 in total

1.  Dose coefficients for organ dosimetry in tomosynthesis imaging of adults and pediatrics across diverse protocols.

Authors:  Shobhit Sharma; Anuj Kapadia; Francesco Ria; W Paul Segars; Ehsan Samei
Journal:  Med Phys       Date:  2022-06-21       Impact factor: 4.506

Review 2.  Modulation of Secondary Cancer Risks from Radiation Exposure by Sex, Age and Gonadal Hormone Status: Progress, Opportunities and Challenges.

Authors:  Anat Biegon; Siobhan Cohen; Dinko Franceschi
Journal:  J Pers Med       Date:  2022-04-30

3.  Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms.

Authors:  Lukas M Carter; Chansoo Choi; Simone Krebs; Bradley Jay Beattie; Chan Hyeong Kim; Heiko Schoder; Wesley E Bolch; Adam Leon Kesner
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 11.082

4.  Dose and Dose Rate-Dependent Effects of Low-Dose Irradiation on Inflammatory Parameters in ApoE-Deficient and Wild Type Mice.

Authors:  Annegret Glasow; Ina Patties; Nicholas D Priest; Ronald E J Mitchel; Guido Hildebrandt; Katrin Manda
Journal:  Cells       Date:  2021-11-20       Impact factor: 6.600

5.  Using patient shielding - What is the risk?

Authors:  Peter Hiles
Journal:  Br J Radiol       Date:  2021-08-04       Impact factor: 3.629

Review 6.  Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses.

Authors:  Mark P Little; Richard Wakeford; Simon D Bouffler; Kossi Abalo; Michael Hauptmann; Nobuyuki Hamada; Gerald M Kendall
Journal:  Environ Int       Date:  2021-12-24       Impact factor: 13.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.